Celcuity (CELC) Long-Term Deferred Tax (2020 - 2022)
Celcuity's (CELC) quarterly Long-Term Deferred Tax came in at $7.0 million in Q4 2022, up 43.34% YoY from $4.9 million in Q4 2021, and up 43.34% on a QoQ basis from $4.9 million in Q4 2021.
Analysis
Celcuity (CELC) Long-Term Deferred Tax (2020 - 2022) Analysis & Trends
Celcuity (CELC) has 3 years of Long-Term Deferred Tax data on file, last reported at $7.0 million in Q4 2022.
- Quarterly Long-Term Deferred Tax rose 43.34% year-over-year to $7.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $7.0 million (up 43.34% YoY) and the FY2022 annual result came in at $7.0 million, up 43.34% from the prior year.
- Long-Term Deferred Tax improved to $7.0 million in Q4 2022, from $4.9 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $7.0 million in Q4 2022 to a low of $3.2 million in Q4 2020.
- A 3-year average of $5.1 million and a median of $4.9 million in 2021 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax surged 51.6% — and 2022, when it surged 43.34%.
- Tracing CELC's Long-Term Deferred Tax over 3 years: stood at $3.2 million in 2020, then surged by 51.6% to $4.9 million in 2021, then jumped by 43.34% to $7.0 million in 2022.
- The last three Long-Term Deferred Tax figures came in at $7.0 million (Q4 2022), $4.9 million (Q4 2021), and $3.2 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 4.92 Mn |
| Dec 31, 2020 | 3.24 Mn |